Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News

© Reuters. FILE PHOTO: The logo of Sanofi is seen a the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File PhotoDeliberations are ongoing and there is no certainty they will result in an agreement, the report said, adding that Mirati could also attract interest from other suitors.

The U.S. health regulator had in December approved Mirati's lung cancer drug, Krazati, to treat adults with advanced lung cancer. In November last year, Bloomberg had reported that Mirati was drawing takeover interest from large pharmaceutical companies.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 450. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Indonesia Berita Terbaru, Indonesia Berita utama